FVB.129(Cg)-Bmxtm1Ali/Oulu

Status

Available to order

EMMA IDEM:09799
International strain nameFVB.129(Cg)-Bmxtm1Ali/Oulu
Alternative nameBmx KO
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolBmxtm1Ali,
Gene/Transgene symbolBmx

Information from provider

ProviderKari Alitalo
Provider affiliationResearch Programs Units, University of Helsinki
Genetic informationDeletion of the Bmx gene.
Phenotypic informationHomozygous:
No obvious phenotype in unchallenged knock-out mice (Rajantie et al. 2001). Decreased tumor growth and tumor angiogenesis in several experimental tumor models (Holopainen et al. 2012).

Heterozygous:
In DMBA-TPA induced skin cancer model: no significant changes between Bmx+/0 and Bmx-/0 males. Increased tumor growth in Bmx+/- females but decreased tumor numbers in Bmx-/- females compared to Bmx+/+ females (Holopainen et al. 2012).
Breeding historyOriginal background DBA/2, backcrossed into C57BL/6 at least 8 times and further into FVB strain at least 5 times.
References
  • Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium.;Rajantie I, Ekman N, Iljin K, Arighi E, Gunji Y, Kaukonen J, Palotie A, Dewerchin M, Carmeliet P, Alitalo K, ;2001;Molecular and cellular biology;21;4647-55; 11416142
  • Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth.;Holopainen Tanja, López-Alpuche Vanessa, Zheng Wei, Heljasvaara Ritva, Jones Dennis, He Yun, Tvorogov Denis, D'Amico Gabriela, Wiener Zoltan, Andersson Leif C, Pihlajaniemi Taina, Min Wang, Alitalo Kari, ;2012;Cancer research;72;3512-21; 22593188
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland
Animals used for archivingheterozygous FVB, wild-type FVB
Stage of embryos2-cell

Disease and phenotype information

MGI phenotypes (allele matching)
  • decreased susceptibility to induced arthritis / MGI

Literature references

  • Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium.;Rajantie I, Ekman N, Iljin K, Arighi E, Gunji Y, Kaukonen J, Palotie A, Dewerchin M, Carmeliet P, Alitalo K, ;2001;Molecular and cellular biology;21;4647-55; 11416142
  • Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth.;Holopainen Tanja, López-Alpuche Vanessa, Zheng Wei, Heljasvaara Ritva, Jones Dennis, He Yun, Tvorogov Denis, D'Amico Gabriela, Wiener Zoltan, Andersson Leif C, Pihlajaniemi Taina, Min Wang, Alitalo Kari, ;2012;Cancer research;72;3512-21; 22593188

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).